Abstract
Background Passive exposure to cigarette smoke has negative effects on respiratory health. Childhood cancer survivors (CCS) are at an increased risk for respiratory disease due to treatment regimens that may harm the respiratory system. The objective of this study was to assess the prevalence of parental smoking among CCS and investigate its association with respiratory outcomes.
Procedure As part of the Swiss Childhood Cancer Survivor Study, between 2007 and 2022 we sent questionnaires to parents of children aged ≤16 years who had survived ≥ 5 years after cancer diagnosis. Parents reported on their children’s respiratory outcomes including recurrent upper respiratory tract infections (otitis media and sinusitis), asthma, and lower respiratory symptoms (chronic cough persisting > 3 months, current and exercise wheeze), and on parental smoking. We used multivariable logistic regression to investigate associations between parental smoking and respiratory outcomes.
Results Our study included 1037 CCS (response rate 66%). Median age at study was 12 years (interquartile range [IQR] 10–14). Eighteen percent of mothers and 23% of fathers reported current smoking. CCS exposed to smoking mothers were more likely to have recurrent upper respiratory tract infections (OR 2.1; 95% CI 1.1–3.7) and lower respiratory symptoms (OR 2.0; 95%CI 1.1-3.7). We found no association with paternal smoking.
Conclusions A substantial proportion of CCS in Switzerland have parents who smoke. Exposure to maternal smoking was associated with higher prevalence of upper and lower respiratory problems. Physicians should advise and assist families of CCS in their endeavors to quit smoking.
Introduction
Childhood cancer survivors (CCS) are at increased risk of pulmonary late effects because of their cancer treatment [1]. Chemotherapy, radiotherapy and surgery involving the chest, and hematopoietic stem cell transplantation may affect lung function and cause symptoms such as chronic cough and exercise-induced shortness of breath [2, 3]. Cumulative incidence of adverse pulmonary outcomes continues to increase years after completing cancer treatment [4]. This indicates continuing susceptibility of survivors’ lungs to initiation and exacerbation of pulmonary diseases. Cancer therapies may also result in delayed immune reconstitution, which leaves patients vulnerable to infections well beyond the conclusion of their treatment [5, 6]. Consequently, infectious complications, such as upper respiratory tract infections including sinusitis and otitis media, remain an important cause of late morbidity among survivors, impacting their health and increasing hospitalization rates [6, 7].
Even among otherwise healthy individuals, environmental tobacco smoke is a risk factor for respiratory symptoms and infections. Children exposed to parental tobacco smoke have increased susceptibility to recurrent otitis media, asthma, cough, wheeze, and lower respiratory illnesses [8]. Globally, nearly 40% of children are exposed to tobacco smoke [9]. In Switzerland, almost one-third of children (31%) grow up in homes in which a parent smokes [10]. Parental smoking may have persistent effects on the respiratory systems of children with potential consequences continuing into adulthood [11]. While this is known for the general population, research on the particularly vulnerable group of CCS is lacking. To address this, we examined the prevalence of parental smoking among Swiss CCS aged ≤16 years in a nationwide study and investigated associations between parental smoking and respiratory outcomes.
Methods
The Swiss Childhood Cancer Survivor Study (SCCSS)
The SCCSS is a population-based, long-term follow-up study (www.swiss-ccss.ch) of survivors registered in the Swiss Childhood Cancer Registry (ChCR, www.kinderkrebsregister.ch) [12]. The ChCR is a national registry founded in 1976 that includes all Swiss residents diagnosed before the age of 20 years with leukemias, lymphomas, central nervous system (CNS) tumors, malignant solid tumors, or Langerhans cell histiocytosis [13]. As part of the SCCSS, we sent questionnaires to former cancer patients who survived for five years or more since their initial diagnosis. Detailed methods of the SCCSS have been published elsewhere [12]. For this study, we analyzed questionnaires returned between 2007 and 2022 by parents of CCS younger than 16 years who had answered questions on smoking status and their child’s respiratory problems. The Ethics Committee of the Canton of Bern granted ethical approval to the ChCR and the SCCSS (166/2014; 2021-0146).
Definition of respiratory outcomes
The questionnaires assessed smoking within the family, and children’s respiratory symptoms and infections occurring during the previous 12 months. Questions inquired about the presence of asthma (yes/no), chronic cough lasting longer than three months (yes/no), recurrent sinusitis (yes/no), and recurrent otitis media (yes/no) in CCS. The questionnaires sent after 2015 also asked whether CCS ever had wheezed in their life (yes/no), in the last 12 months (yes/no), and during exercise (yes/no). From those questions, we created three main groups of respiratory outcomes for the analyses: recurrent upper respiratory tract infections (URTI), asthma, and lower respiratory symptoms. Participants with recurrent URTI included those who reported either recurrent sinusitis or recurrent otitis media, or both. Participants with lower respiratory symptoms included those who had either chronic cough, at least one episode of wheeze in the past 12 months, or wheeze during exercise. The original questions are available upon request.
Explanatory variables
Parental smoking
We asked mothers and fathers separately if they had ever smoked. Possible answers were “no, never”, “yes, but stopped”, and “yes, still smoke today”. If data was missing for both the maternal and paternal smoking status, participants were excluded from further analyses. We coded parental smoking as a binary variable (yes/no) where “yes” indicated current smoker and “no” indicated former or never smoker.
Sociodemographic characteristics
We assessed the following sociodemographic characteristics of CCS: age at study, sex, Swiss language region (German, French, or Italian), living situation, parental nationality, education, and employment status. We classified the living situation of CCS as living with both parents, only with the mother, only with the father, or in other circumstances (in a children’s home or with relatives). Parents’ nationality was categorized as Swiss or other. We considered survivors as having a migration background if they had at least one parent whose nationality was other than Swiss. We divided the highest level of education parents attained into three categories: primary schooling (compulsory schooling only, ≤ 9 years), secondary education (vocational training or upper secondary education), or tertiary education (university or technical college education).
Clinical characteristics
We received the following cancer-related variables from the ChCR: age at diagnosis, time since diagnosis, chemotherapy (yes/no), radiotherapy (yes/no), surgery (yes/no), hematopoietic stem cell transplantation (yes/no), relapse status (yes/no), and diagnosis coded according to the International Classification of Childhood Cancer, third edition (ICCC-3) [14].
Statistical analysis
We used medians and interquartile ranges (IQR) for continuous variables and numbers and percentages for categorical variables to describe sociodemographic and clinical characteristics of survivors and parental smoking status. To examine the association between parental smoking and respiratory outcomes, we used logistic regression. First, we fit univariable logistic regression models to identify sociodemographic and clinical factors associated with recurrent URTI, asthma, and lower respiratory symptoms. Exposure variables that showed an association with the outcome variables at a level of p<0.1 were included in a multivariable logistic regression model. We incorporated maternal and paternal smoking, sex, and age a priori. All respiratory outcomes had a low number of missing answers (<10%), so we assumed that the respective respiratory disease or symptom was absent. If there were missing values in other independent or dependent variables, complete case analysis was performed. We used Stata (Version 16.1, Stata Corporation, Austin, TX) for all analyses.
Results
Characteristics of the study population
Of the 1846 eligible survivors identified through the Swiss Childhood Cancer Registry, we sent the parents of 1628 a questionnaire. Questionnaires were returned by parents in 1070 families (a response rate of 66%). We excluded questionnaires of 33 survivors for whom we found no answers to any of the questions on parental smoking or on respiratory outcomes. The final dataset used for the analysis thus included 1037 children (Figure 1). Their median age at study was 12 years (interquartile range [IQR] 10-14), median age at diagnosis was 3 years (IQR 2-5), and median time since diagnosis 8 years (IQR 7-10). The most common diagnoses were leukemia (39%), CNS tumors (16%), and neuroblastoma (9%) (Table 1).
a Special cases were identified after contacting clinics where survivors had been treated to evaluate eligibility and to exclude patients with current conditions that preclude contact (e.g., recent relapse, palliative situation)
Among parents, median age at study was 43 years for mothers (IQR 40-47) and 46 years for fathers (IQR 42-50) (Supplemental Table S1). Secondary education was the most frequently attained education level of mothers (50%), while tertiary education was the level achieved by the highest proportion of fathers (49%). Almost all survivors lived with both parents (86%) (Table 1). Most fathers (80%), but only 10% of mothers worked full-time (Supplemental Table S1).
Prevalence of parental smoking
Among mothers, 18% indicated that they currently smoked (95% confidence interval [CI] 15-20%), 22% said they were former smokers who had stopped before the study (95%CI 19-25%), and 60% had never smoked (95%CI 57-63%) (Supplemental Table S1). Among fathers, 24% were active smokers at the time of the study (95%CI 21-27%), 24% were former smokers (95%CI 22-27%), and 52% had never smoked (95%CI 49-55%). In 11% of families, both parents smoked (95%CI 9-13%), and in 20% only one parent was an active smoker (95%CI 18-23%). In most families, none of the parents smoked (69%, 95%CI 66-72%) (Supplemental Figure S1). Smoking was more common in parents with a lower educational level, and among unemployed fathers (Supplemental Table S2).
Prevalence of respiratory outcomes
Eight percent of survivors reported recurrent upper respiratory tract infections (95%CI 7-10%), while asthma was reported by 5% (95%CI 4-7%) (Table 2). In total, 6% of survivors reported lower respiratory symptoms (95%CI 5-8%), including 2% with chronic cough (95%CI 1-3%), 6% with wheeze (95%CI 4-8%), and 6% with wheeze during exercise (95%CI 4-8%). Almost one-third of the survivors with lower respiratory symptoms (32%) reported more than one of these symptoms.
Associations between parental smoking and respiratory outcomes
In multivariable regression, survivors whose mothers smoked were more likely to have recurrent URTI (odds ratio [OR] 2.1, 95%CI 1.1-3.7) and lower respiratory symptoms (OR 2.0, 95%CI 1.1-3.7) compared to survivors whose mothers did not smoke (Figure 2, Supplemental Table S3). Paternal smoking was unrelated to recurrent URTI, asthma, and lower respiratory symptoms.
Abbreviation: URTI, upper respiratory tract infections; OR, odds ratio.
Older survivors were less likely have recurrent URTI (OR 0.9, 95%CI 0.8-1.0). With increasing time since diagnosis, survivors were less likely to have recurrent URTI in the univariable regression (OR 0.9, 95%CI 0.8-1.0), but this effect was not seen after adjusting in the multivariable regression (OR 0.9, 95%CI 0.8-1.1). Survivors with a history of relapse were more likely to have lower respiratory symptoms (OR 1.9, 95%CI 1.0-3.8). Sex was not associated with any of the respiratory outcomes. Detailed results from univariable logistic regression can be found in Supplemental Table S4.
Discussion
A substantial proportion of young childhood cancer survivors in this nationwide, population-based cohort study is exposed to parents who smoke (31%). We found that maternal smoking in these families was associated with two-fold increased risk of recurrent upper respiratory tract infections and lower respiratory symptoms.
Prevalence of parental smoking
Despite the general decline in smoking worldwide over the past two decades [15, 16], our study found that a significant proportion of Swiss CCS are exposed to parental smoking, with 18% of mothers and 24% of fathers reported as smokers. A school-based survey on children’s respiratory health conducted in the Canton of Zurich between 2013 and 2016 found slightly higher rates, with 20% of mothers and 30% of fathers smoking [17]. Similarly, a 2017 nationwide report on tobacco use by the Swiss Federal Statistical Office indicated that 23% of women and 31% of men aged 15 and older were daily or occasional smokers [16]. Yet little is known about parental smoking in the families of CCS. A study conducted in the USA found that only 6% of parents of CCS were active smokers compared to 12% of adults in the general population [18, 19]. The lower prevalence among parents of CCS may be because parents of survivors tend to adopt more health-conscious behaviors [18]. However, it could also be that underreporting is more common in this population.
Associations with respiratory outcomes
Maternal smoking was associated with a greater risk of recurrent upper respiratory tract infections and lower respiratory symptoms among young (<16 years) childhood cancer survivors in our study. These results are in line with questionnaire-based studies in the general population that consistently have found a stronger impact of maternal smoking on respiratory health than paternal smoking [20–23]. Women are more often primary caregivers and spend more time on average at home with their children [24]. In our study, almost all of the CCS lived with both parents (86%) or only their mothers (13%), and there was a pronounced difference between employment status of parents, with only 10% of mothers having full-time jobs compared to 80% of fathers. This suggests that survivors may be more susceptible to the adverse effects of maternal smoking due to increased exposure to tobacco smoke within the household environment.
Passive smoking contributes to respiratory morbidity in children [8]. In the late 1990s, a series of comprehensive systematic reviews with meta-analyses revealed consistent evidence for associations between maternal smoking and recurrent otitis media (OR 1.48, 95%CI 1.08-2.04) [25], wheeze (OR 1.28, 95% CI 1.19-1.38) and cough (OR 1.40, 95%CI 1.20-1.64). [26] A multicountry, questionnaire-based study of 220 407 children (6-7 years) and 350 654 adolescents (13-14 years) found that maternal smoking was associated with wheeze both in children (OR 1.28, 95%CI 1.22-1.34) and adolescents (OR 1.32, 95%CI 1.26-1.37) [21]. Compared to those results, our observations in CCS indicated slightly stronger associations between maternal smoking and recurrent upper respiratory tract infections and lower respiratory symptoms. Survivors with a history of relapse were more likely to experience lower respiratory symptoms, perhaps because of more intense and prolonged treatments including chemotherapy, radiation, and hematopoietic stem cell transplantation [27, 28].
In contrast to previous studies conducted among the general population [21–23, 29, 30], we found no association between parental smoking and asthma. A systematic review found that children whose parents smoked were more likely to have asthma than children with nonsmoking parents (OR 1.21, 95%CI 1.10-1.34) [31]. The lack of association observed in our study may be due to underreporting or underdiagnosing of asthma. Several studies have found that children with parents who smoke were less likely to receive an asthma diagnosis [32, 33]. This could be because parents who smoke are less likely to seek medical advice regarding mild respiratory symptoms that could be related to smoking in the family [32, 33]. A comprehensive literature summary of previous studies can be found in the supplement (Supplemental literature summary).
Limitations and strengths
The cross-sectional design of this study does not allow causal conclusions regarding smoking and respiratory outcomes. However, the biological plausibility connecting passive smoking and respiratory conditions is well established [8]. Passive tobacco smoke has toxic effects on the mucosa, impairs ciliary function and local immune defenses, and results in prolonged inflammation and susceptibility to infections such as otitis media and sinusitis [34]. It also contributes to airway thickening and irritation thereby predisposing children to respiratory symptoms including wheeze and cough [35]. Self-reported exposures and outcomes may have been subject to recall bias and led to misclassification of some respiratory outcomes. Our study also had limited statistical power because of the low number of respiratory events. Therefore, we could not determine associations between parental smoking and respiratory outcomes within different diagnostic and cancer treatment subgroups.
The strengths of our study include the population-based design and a high response rate, which ensured that the study population is representative of CCS in Switzerland. We used high quality clinical information based on medical records from the Swiss Childhood Cancer Registry and assessed a diverse spectrum of respiratory outcomes.
In conclusion, our study found that exposure to parental smoking is associated with increased risk of respiratory symptoms and infections among Swiss childhood cancer survivors. Further study of smoking in families of CCS is needed and would benefit from a longitudinal design and a control group of children without a cancer history. In the meantime, particularly given definitive evidence of the harm of passive smoking, the integration of parental smoking cessation strategies in childhood cancer patients’ medical and psychosocial care is essential to create a healthier home environment and promote respiratory health in this vulnerable population.
Conflict of interest statement
The authors declare there is no conflict of interest related to the study.
Funding
This work was supported by the Swiss Cancer Research and Swiss Cancer League (Grant no. KFS-5027-02-2020, KFS-5302-02-2021, KLS/KFS-4825-01-2019, KLS/KFS-5711-01-2022), Childhood Cancer Switzerland, Kinderkrebshilfe Schweiz, Stiftung für krebskranke Kinder - Regio Basiliensis, and the University of Basel Research Fund for Excellent Junior Researchers.
SUPPLEMENTAL LITERATURE SUMMARY
Acknowledgements
We thank all survivors for participating in our study, the study team of the Childhood Cancer Research Group, the data managers of the Swiss Paediatric Oncology Group, and the team of the Swiss Childhood Cancer Registry. We also thank Christopher Ritter for editorial assistance.
List of abbreviations
- CCS
- Childhood Cancer Survivor
- SCCSS
- Swiss Childhood Cancer Survivor Study
- ChCR
- Swiss Childhood Cancer Registry
- CNS
- Central Nervous System
- URTI
- Upper Respiratory Tract Infections
- IQR
- Interquartile Range
- CI
- Confidence Interval
- OR
- Odds Ratio
- USA
- United States of America
References
References
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
- 9.
- 10.
- 11.
- 12.
- 13.
- 14.
- 15.
- 16.
- 17.
- 18.
- 19.
- 20.
- 21.